Zobrazeno 1 - 9
of 9
pro vyhledávání: '"35"'
Autor:
Borhane Annabi, Cyndia Charfi, Jean-Christophe Currie, Alain Zgheib, Alain Larocque, Richard Béliveau, Christian Marsolais, Michel Demeule
Publikováno v:
Cancer Research. 80:P3-10
Background: Triple-negative breast cancer (TNBC) still lacks defined molecular biomarkers. Thus, targeting of specific gene/protein molecular signature of tumors emerged among the best anticancer strategies. Recently, increased expression of the cell
Autor:
S. Giacchetti, D. Groheux, A. Hamy, E. Hindie, C. Cuvier, J. Lehmann-Che, A. de Roquancourt, M. Albiter, M. Marty, J. Moretti, M. Espie
Publikováno v:
Cancer Research. 69:5010-5010
Background: This study analysed the correlation between [18F]fluorodeoxyglucose (FDG) uptake, assessed by positron emission tomography (PET), and prognostic factors in locally advanced breast cancersMaterial and Methods: All locally advanced breast c
Autor:
Andrea V. Barrio, Monica Morrow, Tracy-Ann Moo, Giacomo Montagna, Hiram S. Cody, Mary L. Gemignani, Kimberly J. Van Zee, Anita Mamtani, Lisa M. Sclafani, Varadan Sevilimedu, Melissa Pilewskie, Alexandra S. Heerdt, Mahmoud El-Tamer, George Plitas
Publikováno v:
Cancer Research. 81:PD4-05
Background: Four prospective multi-institutional trials have demonstrated that clinically node-positive patients (cN1) who receive neoadjuvant therapy (NAC) and convert to cN0 can be reliably staged with sentinel lymph node biopsy (SLNB) with false-n
Autor:
Rita A. Mukhtar, Jasmine Wong, Kelly Fahrner-Scott, Merisa Piper, Nola M. Hylton, Cheryl Ewing, Michael Alvarado, Laura J. Esserman
Publikováno v:
Cancer Research. 80:PD9-08
Background: Evaluating the size of invasive lobular carcinoma of the breast (ILC) poses a challenge due to higher rates of false negatives compared to invasive ductal carcinoma. Magnetic resonance imaging (MRI) is often considered the best imaging mo
Autor:
D van den Bongard, Tobias Lekberg, F van der Leij, P. Elkhuizen, E.J.T. Rutgers, Harry Bartelink, Sofia Rivera
Publikováno v:
Cancer Research. 73:P5-14
Background The ongoing Preoperative Accelerated Partial Breast Irradiation (PAPBI) trial (NCT01024582) was based on the rationale that three-dimensional conformal external-beam radiation (3D-CRT) leads to more dose homogeneity compared with brachy-or
Autor:
M Racca, Stefania Redana, T Varetto, G. Zago, L Evangelista, Filippo Montemurro, Massimo Aglietta, Carolis V De
Publikováno v:
Cancer Research. 71:P1-18
Background: a small percentage of breast cancer (BC) patients (pts) will develop oligo-metastatic disease (OMD), often with a solitary lesion (SL). Growing evidences suggest a survival benefit for pts who undergo local treatment for SL. However, 18-f
Publikováno v:
Cancer Research. 71:P5-11
Background: The phenotype of TNBC is defined by absence of estrogen (ER) and progesterone receptors (PR) and lack of amplification of the HER2 oncogene. It is an aggressive form of breast cancer, and despite sensitivity to contemporary chemotherapy,
Publikováno v:
Cancer Research. 74:1880-1880
Background: Several ways to assess pathologic response of breast cancer after neoadjuvant chemotherapy (NAC) are currently used, including Miller-Payne system and residual cancer burden. However, the relationship between pathologic response pattern a
Autor:
Alice Mege, C. Lemanski, Christelle Levy, Catherine Delva, Mariano Provencio, M Baron, Bruno Cutuli, Lorenzo Livi, P. Kerbrat, C. Tunon de Lara, L. Gonzague-Casabianca
Publikováno v:
Cancer Research. 69:6153
Abstract #6153 Background Breast cancer (BC) is the most frequent second malignancy in women treated for Hodgkin's disease (HD), but there are few specific data on these tumors. This study assesses histopathological features, locoregional and systemi